Common gene test to predict breast cancer recurrence may not be cost-effective

[News]

The most commonly used gene expression profile test used to help predict breast cancer recurrence may not be as cost-effective as once thought, say a team of researchers led by Georgetown Lombardi Comprehensive Cancer Center.

More... (https://www.news-medical.net/news/20180109/Common-gene-test-to-predict-breast-cancer-recurrence-may-not-be-cost-effective.aspx)